File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1039/c1cc10860c
- Scopus: eid_2-s2.0-80051722314
- PMID: 21674082
- WOS: WOS:000293858700001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment
Title | Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment |
---|---|
Authors | |
Issue Date | 2011 |
Publisher | Royal Society of Chemistry. The Journal's web site is located at http://www.rsc.org/Publishing/Journals/cc/index.asp |
Citation | Chemical Communications, 2011, v. 47 n. 34, p. 9554-9560 How to Cite? |
Abstract | Gold and its complexes have long been known to display unique biological and medicinal properties. Extensive cell-based (in vitro) and animal (in vivo) studies have revealed the potent anti-cancer activities of diverse classes of gold(I) and gold(III) complexes. Most of the reported anti-cancer active gold complexes are highly cytotoxic and unstable under physiological conditions, which hamper their development to be launched clinically. Several clinical reports showed that lipophilic organic cations are promising anti-cancer drug candidates targeting to mitochondria. Through metal-ligand coordination, gold(I) and gold(III) ions can form stable lipophilic cations containing organic ligands having tunable lipophilicity and diverse functionalities. The present highlight summarizes the recent development of lipophilic gold(III) cations and gold(I) complexes with promising anti-cancer activities. |
Persistent Identifier | http://hdl.handle.net/10722/159401 |
ISSN | 2023 Impact Factor: 4.3 2023 SCImago Journal Rankings: 1.133 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Che, CM | en_HK |
dc.contributor.author | Sun, RWY | en_HK |
dc.date.accessioned | 2012-08-16T05:49:06Z | - |
dc.date.available | 2012-08-16T05:49:06Z | - |
dc.date.issued | 2011 | en_HK |
dc.identifier.citation | Chemical Communications, 2011, v. 47 n. 34, p. 9554-9560 | en_HK |
dc.identifier.issn | 1359-7345 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/159401 | - |
dc.description.abstract | Gold and its complexes have long been known to display unique biological and medicinal properties. Extensive cell-based (in vitro) and animal (in vivo) studies have revealed the potent anti-cancer activities of diverse classes of gold(I) and gold(III) complexes. Most of the reported anti-cancer active gold complexes are highly cytotoxic and unstable under physiological conditions, which hamper their development to be launched clinically. Several clinical reports showed that lipophilic organic cations are promising anti-cancer drug candidates targeting to mitochondria. Through metal-ligand coordination, gold(I) and gold(III) ions can form stable lipophilic cations containing organic ligands having tunable lipophilicity and diverse functionalities. The present highlight summarizes the recent development of lipophilic gold(III) cations and gold(I) complexes with promising anti-cancer activities. | en_HK |
dc.language | eng | en_US |
dc.publisher | Royal Society of Chemistry. The Journal's web site is located at http://www.rsc.org/Publishing/Journals/cc/index.asp | en_HK |
dc.relation.ispartof | Chemical Communications | en_HK |
dc.subject.mesh | Antineoplastic Agents - chemistry - pharmacology - therapeutic use | - |
dc.subject.mesh | Cell Line, Tumor | - |
dc.subject.mesh | Gold - chemistry | - |
dc.subject.mesh | Hydrophobic and Hydrophilic Interactions | - |
dc.subject.mesh | Organometallic Compounds - chemistry - pharmacology - therapeutic use | - |
dc.title | Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Che, CM: cmche@hku.hk | en_HK |
dc.identifier.email | Sun, RWY: rwysun@hku.hk | en_HK |
dc.identifier.authority | Che, CM=rp00670 | en_HK |
dc.identifier.authority | Sun, RWY=rp00781 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1039/c1cc10860c | en_HK |
dc.identifier.pmid | 21674082 | - |
dc.identifier.scopus | eid_2-s2.0-80051722314 | en_HK |
dc.identifier.hkuros | 205317 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-80051722314&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 47 | en_HK |
dc.identifier.issue | 34 | en_HK |
dc.identifier.spage | 9554 | en_HK |
dc.identifier.epage | 9560 | en_HK |
dc.identifier.eissn | 1364-548X | - |
dc.identifier.isi | WOS:000293858700001 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Sun, RWY=26325835800 | en_HK |
dc.identifier.scopusauthorid | Che, CM=7102442791 | en_HK |
dc.identifier.issnl | 1359-7345 | - |